AI in Hematopathology: How Digital Smears Enable Automated Blood Cell Classification Key Takeaways AI-powered digital microscopy is revolutionizing blood cell analysis, achieving diagnostic accuracy rates up to 95% while dramatically reducing processing time and improving statistical reliability through massive cell analysis capabilities. AI achieves
Oncology
Stool Testing vs Colonoscopy After a Positive FIT: How Fast Is Fast Enough?
Stool Testing vs Colonoscopy After a Positive FIT: How Fast Is Fast Enough? Abstract A positive fecal immunochemical test (FIT) represents a critical juncture in colorectal cancer screening, signaling the need for timely diagnostic evaluation to identify underlying neoplasia. Following a positive result, patients
The New Margin Wars in Oncology: Less Is More…Until It Isn’t
Thyroid Cancer Overdiagnosis: When Screening Causes More Harm Than Good
Thyroid Cancer Overdiagnosis When Screening Causes More Harm Than Good Abstract The incidence of thyroid cancer has risen substantially over the past three decades, drawing increased attention from clinicians, researchers, and public health authorities. Much of this rise has been attributed not to a true surge in aggressive
Why Biomarker-Driven Treatment Fails: The Hidden Role of Histology
Why Biomarker-Driven Treatment Fails The Hidden Role of Histology Introduction Biomarker-driven treatment has fundamentally transformed oncology, ushering in an era of precision medicine in which therapeutic decisions are increasingly guided by the molecular characteristics of tumors rather than their anatomical origin alone. A
Targeting the Bone Marrow Microenvironment in Myeloma and Acute Myeloid Leukemia: Novel Therapeutic Approaches and Clinical Implications
Targeting the Bone Marrow Microenvironment in Myeloma and Acute Myeloid Leukemia Novel Therapeutic Approaches and Clinical Implications Abstract The bone marrow microenvironment is increasingly recognized as a central determinant in the initiation, progression, and therapeutic resistance of hematologic malignancies, particularly multiple myeloma and acute myeloid leukemia
Bite Therapy: CAR-T vs T-Cell Engagers – Which Saves More B-ALL Patients?
Bite Therapy: CAR-T vs T-Cell Engagers – Which Saves More B-ALL Patients? Introduction Bite therapy and CAR-T cell treatments have revolutionized the management of B-cell acute lymphoblastic leukemia (B-ALL), achieving remarkable remission rates. Second-generation CD19-targeted chimeric antigen receptor T cells achieve dramatic remission
Skyrocketing Cancer Drug Prices: Can Oncologists Influence Policy?
Skyrocketing Cancer Drug Prices Can Oncologists Influence Policy Abstract The rapid escalation of cancer drug prices has emerged as a major challenge in contemporary oncology practice, with many newly approved therapies carrying annual costs that exceed one hundred thousand dollars per patient. This
Radioligand Therapy Results: New Evidence in Treating Neuroendocrine Tumors
Radioligand Therapy Results New Evidence in Treating Neuroendocrine Tumors Check out our extensive video library (see channel for our latest videos) Introduction Radioligand therapies have emerged as an important breakthrough in the management of neuroendocrine tumors, a group of heterogeneous neoplasms known
PARP Inhibitors in Pancreatic Cancer: Breaking Beyond BRCA Mutations
PARP Inhibitors in Pancreatic Cancer: Breaking Beyond BRCA Mutations Check out our extensive video library (see channel for our latest videos) Introduction PARP inhibitor therapy for pancreatic cancer represents one of the most significant breakthroughs in precision oncology. These targeted therapies have
